Innovate UK

The synthesis method will be incorporated into the silicon array the company developed to produce DNA at scale.

Businesses can now apply for a share of the funds to develop new technologies that increase the UK's capacity to carry out genomic analysis.

The collaborators aim to show that Cytox' VariaTect SNP profiling array and an associated algorithm can effectively predict the presence of Alzheimer's pathology.

The British company has announced the results of two studies showcasing the ability of its EpiSwitch platform to diagnose and stage breast cancer and ALS patients.

The firm has secured rights to use CRISPR in cell lines for biomanufacturing and will work with Solentim to increase editing throughput while decreasing costs.

The partners plan to develop a computational platform that automates pipelines and processes for biomarker discovery, drug recovery and repositioning, and more.

The national program to set up local innovation hubs will collaborate with regional experts in government, academia, and the healthcare industry.

The company is developing a search application that will allow users to explore genomic datasets without accessing sensitive information.

The consortium comprises Oxford BioDynamics,OxfordUniversityresearchers, and Chronos Therapeutics.

NEW YORK (GenomeWeb) – Horizon Discovery Group today announced it and life sciences measurement and testing firm LGC have received a £360,224 ($612,000) research grant to develop novel reference standard materials for clinical diagnostics.

Pages

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.

Retraction Watch's Ivan Oransky and Adam Marcus report that Harvard Medical School and Brigham and Women's Hospital have recommended that more than 30 papers from a former researcher be retracted.

Thomas Steitz, who won the 2009 chemistry Nobel Prize for his ribosome work, has died, the Washington Post reports.

In PLOS this week: mechanisms for genes implicated in coronary artery disease, rumen microbes and host genetics influence cow methane production, and more.